Ray Dalio started to build up the position in Health Catalyst in Q2 2021 and continued to invest until Q2 2022. Since then they sold 151 Thousand shares. The investor completely sold their stake between Q3 2022 and Q3 2023.
Avg closing price
Price range
Sold -107 Thousand shares
Q3 2023
Avg closing price
$11.94
Price range
$9.35
-
$14.32
Sold 3.8% shares (-4.22 Thousand shares)
Q2 2023
Avg closing price
$11.91
Price range
$9.86
-
$13.12
Sold 0.8% shares (-932 shares)
Q1 2023
Avg closing price
$12.75
Price range
$10.23
-
$14.76
Sold 24.4% shares (-36.3 Thousand shares)
Q4 2022
Avg closing price
$9.65
Price range
$6.47
-
$11.32
Sold 1.6% shares (-2.48 Thousand shares)
Q3 2022
Avg closing price
$13.24
Price range
$9.30
-
$18.27
Increased shares by 20.2% (+25.4 Thousand shares)
Q2 2022
Avg closing price
$17.05
Price range
$11.79
-
$27.63
Increased shares by 33.6% (+31.7 Thousand shares)
Q1 2022
Avg closing price
$28.37
Price range
$20.67
-
$40.33
Increased shares by 8.9% (+7.7 Thousand shares)
Q4 2021
Avg closing price
$45.57
Price range
$36.68
-
$54.02
Increased shares by 7.7% (+6.18 Thousand shares)
Q3 2021